Pharsight

1. List of Conzip drug patents

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7858118	CIPHER PHARMS INC	Extended release composition containing Tramadol	Apr, 2022 (9 months ago)

Market Authorisation Date: 07 May, 2010

Treatment: Use of tramadol for the management of moderate to moderately severe chronic pain

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

Strength	Dosage	Availability
100MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription
150MG	CAPSULE, EXTENDED RELEASE;ORAL	Discontinued
200MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription
300MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103452	ATHENA	Tramadol hydrochloride solution	Sep, 2040 (17 years from now)

Market Authorisation Date: 01 September, 2020

Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Dosage: SOLUTION;ORAL

Strength	Dosage	Availability
5MG/ML	SOLUTION;ORAL	Prescription

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7988998	PURDUE PHARMA	Sustained-release tramadol formulations with 24-hour efficacy	Oct, 2023 (8 months from now)